Literature DB >> 8203864

Fever and associated changes in glomerular filtration rate erase anticipated diurnal variations in aminoglycoside pharmacokinetics.

F Fauvelle1, P Perrin, L Belfayol, M Boukari, P Cherrier, A M Bosio, M Tod, J M Coulaud, O Petitjean.   

Abstract

Netilmicin (4.5 mg/kg of lean body weight) was administered intravenously once every 24 h at 10 a.m. to 23 patients (group I) and at 10 p.m. to 20 patients (group II) with severe infection. No significant differences (P > 0.05) in peak and trough concentrations in serum were found between groups I and II (peak, 12.9 +/- 3.7 versus 12.8 +/- 4.4 mg/liter, respectively; trough, 0.7 +/- 0.6 versus 0.8 +/- 0.6 mg/liter, respectively [mean +/- standard deviation]). Pharmacokinetic parameters (half-life [5.0 +/- 2.2 versus 4.9 +/- 1.8 h], volume of distribution [0.32 +/- 0.04 versus 0.35 +/- 0.06 liter/kg], and total clearance [0.920 +/- 0.417 versus 1.015 +/- 0.546 ml/min/kg]) were similar in the two groups and not influenced by the time of administration. These data suggest that, in the once-daily schedule, 10 a.m. or 10 p.m. administration had no influence on netilmicin levels in serum and pharmacokinetic parameters in these ill febrile patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203864      PMCID: PMC284509          DOI: 10.1128/AAC.38.3.620

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.

Authors:  G Beaucaire; O Leroy; C Beuscart; P Karp; C Chidiac; M Caillaux
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

3.  The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.

Authors:  P E Marik; I Havlik; F S Monteagudo; J Lipman
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

4.  Forecasting individual pharmacokinetics.

Authors:  L B Sheiner; S Beal; B Rosenberg; V V Marathe
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

5.  Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharm Sci       Date:  1982-12       Impact factor: 3.534

6.  Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever.

Authors:  J E Pennington; D C Dale; H Y Reynolds; J D MacLowry
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

Review 7.  Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982.

Authors:  G Kahlmeter; J I Dahlager
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

8.  Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.

Authors:  S H Powell; W L Thompson; M A Luthe; R C Stern; D A Grossniklaus; D D Bloxham; D L Groden; M R Jacobs; A O DiScenna; H A Cash; J D Klinger
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

9.  Increased gentamicin dosage requirements: rapid elimination in 249 gynecology patients.

Authors:  D E Zaske; R J Cipolle; R G Strate; W F Dickes
Journal:  Am J Obstet Gynecol       Date:  1981-04-15       Impact factor: 8.661

10.  The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure.

Authors:  W M Bennett; C E Plamp; D N Gilbert; R A Parker; G A Porter
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

View more
  3 in total

1.  Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.

Authors:  Laura Kervezee; Jasper Stevens; Willem Birkhoff; Ingrid M C Kamerling; Theo de Boer; Melloney Dröge; Johanna H Meijer; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2015-11-25       Impact factor: 4.335

2.  Chronopharmacokinetics of once daily dosed aminoglycosides in hospitalized infectious patients.

Authors:  Erik van Maarseveen; Wai Hong Man; Johannes Proost; Cees Neef; Daniël Touw
Journal:  Int J Clin Pharm       Date:  2015-01-24

3.  The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison.

Authors:  A P Prayle; K Jain; D J Touw; B C P Koch; A J Knox; A Watson; A R Smyth
Journal:  J Cyst Fibros       Date:  2015-08-15       Impact factor: 5.482

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.